In this episode of Diagnosing Healthtech, we break down the 2024 J.P. Morgan Healthcare conference.
Former healthcare services analyst and current corporate advisor to private and public equity investors, Ryan Halsted of the Gilman Group joins Jeff to break down themes and takeaways from the conference including:
- VC, P/E funding and IPOs
- AI in healthcare and infiltration of big tech
- The pressure on Medicare advantage
- Potential regulation in pharmacy benefit management